Prelude Therapeutics Incorporated (PRLD) market cap

Market cap today
$264.95M

Prelude Therapeutics Incorporated (PRLD) has a market cap of $264.95M. At the end of fiscal 2025 (December 31, 2025) its market cap was $223.17M. That is 130.9% higher than the $96.65M of fiscal 2024. Today's figure is 18.7% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 04:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$264.95M
Market cap, fiscal 2025
$223.17M
Change on fiscal 2024
+130.9%
Highest on record
$573.32Mfiscal 2021
Lowest on record
$96.65Mfiscal 2024
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Prelude Therapeutics Incorporated market cap, in more detail

Across the 5 fiscal year-ends on record (2021–2025), the highest was $573.32M in fiscal 2021 and the lowest $96.65M in fiscal 2024.

History · 5 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Prelude Therapeutics Incorporated market cap, year by year

Prelude Therapeutics Incorporated (PRLD) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$264.95M—$3.32—
2025$223.17M 130.9% up$2.9076.96M
2024$96.65M 62.5% down$1.2775.81M
2023$257.72M 9.9% down$4.2760.36M
2022$286.12M 50.1% down$6.0447.37M
2021$573.32M—$12.4546.05M
2020——$71.55—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on PRLD

Prelude Therapeutics Incorporated, figure by figure

Prelude Therapeutics Incorporated (PRLD) overview: price, valuation and scorecard

Prelude Therapeutics Incorporated market cap: questions and answers

What is Prelude Therapeutics Incorporated's market cap?

Prelude Therapeutics Incorporated (PRLD) has a market cap of $264.95M. At the end of fiscal 2025 (December 31, 2025) its market cap was $223.17M. That is 130.9% higher than the $96.65M of fiscal 2024.

What are the highest and lowest market cap figures on record for Prelude Therapeutics Incorporated?

Across the 5 fiscal year-ends on record (2021–2025), the highest was $573.32M in fiscal 2021 and the lowest $96.65M in fiscal 2024.

How is Prelude Therapeutics Incorporated's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Prelude Therapeutics Incorporated (PRLD) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/PRLD/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.